Concepedia

Matthew Mei

MM

65

Publications

2.9K

Citations

30

H-Index

2005

Active since

Affiliations

City of Hope(Current)

City Of Hope National Medical Center

The University of Texas MD Anderson Cancer Center

Fred Hutch Cancer Center

Dana-Farber Cancer Institute

Matthew Mei is an author at City of Hope specializing in medicine, immunology, and oncology.

ORCID

Top concepts

Publications per year

2005–2024

65

Publications

65

Axicabtagene Ciloleucel in the Non-Trial Setting: Outcomes and Correlates of Response, Resistance, and Toxicity

Caron A. Jacobson, Bradley D. Hunter, Robert Redd et al. · Journal of Clinical Oncology · 2020 · 332 citations · Full text

Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation

Alex F. Herrera, Matthew Mei, Lawrence K. Low et al. · Journal of Clinical Oncology · 2016 · 185 citations · Full text

, , +20

Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies

Stephen M. Ansell, Michael B. Maris, Alexander M. Lesokhin et al. · Clinical Cancer Research · 2021 · 183 citations · Full text

Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma

Alex F. Herrera, Michael LeBlanc, Sharon M. Castellino et al. · New England Journal of Medicine · 2024 · 150 citations · Full text

Response-adapted anti-PD-1–based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICE

Matthew Mei, Hun Ju Lee, Joycelynne Palmer et al. · Blood · 2022 · 107 citations · Full text

Rows per page

1–5 of 65